معرفی
Larry Yet serves as an Associate Professor in the Department of Chemistry within the College of Arts and Sciences at the University of South Alabama. His academic appointment includes teaching responsibilities spanning undergraduate general chemistry courses to specialized graduate-level instruction in organic and medicinal chemistry.
His educational background includes a B.S. in Chemistry from the University of British Columbia (1987), followed by M.S. and Ph.D. studies in Organic Chemistry at Ohio State University (1987-1995), and postdoctoral training in Chemistry & Biochemistry at the University of Delaware (1994-1996).
Research interests center on medicinal chemistry approaches to anticancer drug discovery, with emphasis on synthesizing biologically active heterocyclic natural products. His group develops transition metal-catalyzed reactions to streamline synthetic routes, creates ligands for cross-coupling and C-H activation, and establishes structure-activity relationships through biological assays. Key research themes include heterocyclic chemistry, enzyme inhibition strategies, and methodology development for complex molecule synthesis.
Publication analysis reveals consistent focus on heterocyclic chemistry applications in drug discovery, particularly five- and six-membered nitrogen-containing ring systems. His work bridges synthetic methodology development with biological target validation, especially in anticancer contexts involving phosphodiesterase inhibitors, protein phosphatases, and kinase targets. Recent publications demonstrate strong industry-academic collaboration patterns.
Teaching philosophy emphasizes conceptual understanding over rote memorization, with case studies illustrating real-world applications. His approach aims to build foundational knowledge for undergraduate chemists while developing critical thinking skills for graduate students targeting careers in pharmaceuticals, petroleum, and specialty chemicals industries.
Laboratory work involves state-of-the-art organic synthesis techniques applied to biologically relevant targets, with research groups functioning as integrated teams focused on translational drug discovery projects. Current efforts continue to explore novel synthetic methodologies for heterocyclic systems with therapeutic potential.
